ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2031

Online Viewing of Labs in RA Patients Is Not Associated with Clinically Significant Change in ESR over 18 Months Compared to Non-Viewers

Sheryl Mascarenhas1, Shuvro Roy2, April Pinto2 and Preeta Gupta2, 1Rheumatology, The Ohio State University, Columbus, OH, 2The Ohio State University, Columbus, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Electronic Health Record, laboratory tests and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   As part of passage of the Affordable Care Act in 2010, Meaningful Use Core Measures were outlined to improve electronic medical record (EMR) systems.  One of these such measures is enabling patients to electronically view laboratory results.  Allowing patients to view and track their labs can improve patient engagement in their medical care.  However whether increased electronic patient engagement results in better clinical outcomes is not yet known.  We reviewed whether viewing labs amongst rheumatoid arthritis patients resulted in improvement in laboratory results over an 18 month period.

Methods: Data was obtained from a retrospective chart review of rheumatoid patients seen at the Ohio State University Rheumatology Clinics.  The cohort included patients who had an ICD-9 or ICD-10 diagnosis consistent with rheumatoid arthritis.  The most recent sedimentation rate (ESR) and an ESR 18 months prior were recorded as the two outcome measures. Patients were divided into a group who had viewed their labs online and a group that did not, which could be determined from our EMR tracking system.  The difference between the ESR over the 18 months was calculated and a one tailed t test was done between the 2 groups.

Results: 173 patients were included in the study with 111 of the patients not viewing their labs online (Non-viewers) and 62 having viewed the labs online (viewers).  138 of the patients were female (79.8%), with a mean age of 56.6 ±12.4 years.  Baseline ESR were similar between both groups.  At 18 months there was a statistically significant difference (p=0.039) in the ESR of 31.68 ±27.12 mm/hour in Non-viewers compared to 23.87 ±19.61 mm/hour in Viewers. However the degree of change in the ESR over the 2 data points was not statistically significant (p=0.29).  The change in ESR over 18 months in the Non-viewers was -6.16 ±22.42 mm/hour compared to -8.16 ±23.93 mm/hour in Viewers.

Conclusion:   To our knowledge this is the first study evaluating whether patient viewing of labs online results in a change in laboratory results overtime in rheumatoid arthritis patients.  After 18 months the ESR did improve in both populations, however the degree of change in ESR over the course of 18 months in those who viewed labs online and those who did not was not statistically significant. 

Table 1. Patient Demographics

Non-Viewers

Viewers

Total

111

62

Age (years)

57.22 (±12.68)

55.5 (±11.83)

Female (%)

81.08%

77.40%

Race (n)

     White

59

52

     African American

39

6

     Hispanic

5

0

     Mexican

1

1

     Asian

0

1

     Middle Eastern

2

0

     Asian-Indian

1

0

     Laotian

1

0

     Bengali

1

0

     Somali

1

0

     Other

1

2

 

Table 2. Sedimentation Rate (ESR) For Non-viewers and Viewers

Non-Viewers

Viewers

ESR at start

37.98 (±31.46)

34.48 (±24.03)

p=0.25

ESR at 18 months

31.68 (±27.12)

23.87 (±19.61)

p=0.039

Change in ESR at 18 months

-6.16(±22.42)

-8.16 (±23.93)

p=0.29

 


Disclosure: S. Mascarenhas, None; S. Roy, None; A. Pinto, None; P. Gupta, None.

To cite this abstract in AMA style:

Mascarenhas S, Roy S, Pinto A, Gupta P. Online Viewing of Labs in RA Patients Is Not Associated with Clinically Significant Change in ESR over 18 Months Compared to Non-Viewers [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/online-viewing-of-labs-in-ra-patients-is-not-associated-with-clinically-significant-change-in-esr-over-18-months-compared-to-non-viewers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/online-viewing-of-labs-in-ra-patients-is-not-associated-with-clinically-significant-change-in-esr-over-18-months-compared-to-non-viewers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology